CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
REVENUE, NET
Products	$ 85,740	$ 10,434
Services	125,717
Total revenues, net	211,457	10,434
COST OF REVENUE
Products	78,892	17,758
Services	20,905
Total costs of revenue	99,797	17,758
GROSS MARGIN (LOSS)	111,660	(7,324)
EXPENSES
Sales and marketing	109,626	344,044
General and administrative	444,049	207,146
Depreciation and Amortization	39,749	293
TOTAL OPERATING EXPENSES	593,424	551,483
OPERATING LOSS	(481,764)	(558,807)
Other Income (Expense)
Change in fair value of equity investments		158,929
Interest Expense	(26,164)	(1,879)
Total other (expense), net	(26,164)	157,050
NET LOSS	(507,928)	(401,757)
Less: Net loss attributable to non controlling interest	84,031	6,256
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	$ (423,897)	$ (395,501)
LOSS PER COMMON SHARE	$ (0.03)	$ (0.04)
WEIGHTED AVERAGE SHARES OUTSTANDING
Basic and diluted	13,805,915	10,499,610